Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
(Q40782779)
scientific article
scientific article
Language:
Current Data About
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
1399-1403
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P433) |
9
|
||||||||||||||||||||||||
| (P478) |
22
|
||||||||||||||||||||||||
| (P577) |
Saturday, September 1, 2001
|
||||||||||||||||||||||||
| (P921) |
(Q21014462)
(Q23058136)
|
||||||||||||||||||||||||
| (P1433) |
(Q326022)
|
||||||||||||||||||||||||
| (P1476) |
"Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP." (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Zhu W
Zhang JS
Young CY
|
other details